Back
PTC Therapeutics Stock Price Chart
Sponsored
PTCT
Sponsored
AI DIVIDENDS: No. 1 Way to Collect Passive Income
Click here to get it for free.
Buy
51
PTCT
PTC Therapeutics
Last Price:
41.58
Seasonality Move:
28.78%
7 Day Trial
ALL ACCESS PASS
$
7
Gold Set to Skyrocket as Fed Slashes Rates
Click here for the details on this incredible opportunity.- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PTCT is experiencing buying pressure, which is a positive indicator for future bullish movement.
PTC Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 40.56 | Buy |
20-day SMA: | 38.7 | Buy |
50-day SMA: | 36.24 | Buy |
200-day SMA: | 32.19 | Buy |
8-day EMA: | 40.64 | Buy |
20-day EMA: | 39.1 | Buy |
50-day EMA: | 36.96 | Buy |
200-day EMA: | 33.81 | Buy |
PTC Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.53 | Buy |
Relative Strength Index (14 RSI): | 64.54 | Buy |
Chaikin Money Flow: | 497919 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (36.22 - 40.54) | Buy |
Bollinger Bands (100): | (32.07 - 37.69) | Buy |
PTC Therapeutics Technical Analysis
Oct 15 | Oct 16 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | ||||||||||
15 | 16 | 18 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for PTC Therapeutics Stock
Is PTC Therapeutics Stock a Buy?
- PTC Therapeutics share price is 42.50 while PTCT 8-day simple moving average is 40.56, which is a Buy signal.
- The stock price of PTCT is 42.50 while PTC Therapeutics 20-day SMA is 38.70, which makes it a Buy.
- PTC Therapeutics 50-day simple moving average is 36.24 while PTCT share price is 42.50, making it a Buy technically.
- PTCT stock price is 42.50 and PTC Therapeutics 200-day simple moving average is 32.19, creating a Buy signal.
PTCT Technical Analysis vs Fundamental Analysis
Buy
51
PTC Therapeutics (PTCT)
is a Buy
Is PTC Therapeutics a Buy or a Sell?
-
PTC Therapeutics stock is rated a Buy
The current PTC Therapeutics [PTCT] share price is $42.50. The Score for PTCT is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
PTC Therapeutics Stock Info
Market Cap:
3.27B
Price in USD:
42.50
Share Volume:
502.47K
PTC Therapeutics 52-Week Range
52-Week High:
43.40
52-Week Low:
17.53
Buy
51
PTC Therapeutics (PTCT)
is a Buy
PTC Therapeutics Share Price Forecast
-
What is the PTC Therapeutics stock price today?
The PTC Therapeutics stock price is 42.50 USD today. -
Will PTCT stock go up or go down?
PTC Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is PTC Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, PTC Therapeutics is not overvalued.
Is PTC Therapeutics Stock a Buy?
- PTC Therapeutics share price is 42.50 while PTCT 8-day exponential moving average is 40.64, which is a Buy signal.
- The stock price of PTCT is 42.50 while PTC Therapeutics 20-day EMA is 39.10, which makes it a Buy.
- PTC Therapeutics 50-day exponential moving average is 36.96 while PTCT share price is 42.50, making it a Buy technically.
- PTCT stock price is 42.50 and PTC Therapeutics 200-day simple moving average is 33.81, creating a Buy signal.
Fundamental Analysis of PTC Therapeutics
Is PTC Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.98 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.99 per share, and an increase next year of $0.74 per share.
Technical Analysis of PTC Therapeutics
Should I short PTC Therapeutics stock?
- PTCT Moving Average Covergence Divergence (MACD) indicator is 1.53, suggesting PTC Therapeutics is a Buy
- PTC Therapeutics Relative Strength Index (RSI) is 64.54, which suggest PTC Therapeutics is overbought
- The Bollinger Bands (25) for PTC Therapeutics is (36.22 - 40.54), which suggest PTC Therapeutics is a Buy
- The Bollinger Bands (100) for PTC Therapeutics is (32.07 - 37.69), which suggest PTC Therapeutics is a Buy
* PTC Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.